State Street’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-30,507
Closed -$3.39K 4876
2022
Q4
$3.39K Hold
30,507
﹤0.01% 4844
2022
Q3
$32K Hold
30,507
﹤0.01% 4754
2022
Q2
$57K Sell
30,507
-4,383
-13% -$10.7K ﹤0.01% 4700
2022
Q1
$125K Sell
34,890
-14,610
-30% -$71.8K ﹤0.01% 4572
2021
Q4
$426K Hold
49,500
﹤0.01% 4077
2021
Q3
$376K Buy
49,500
+9,800
+25% +$82.6K ﹤0.01% 4089
2021
Q2
$264K Sell
39,700
-41,491
-51% -$262K ﹤0.01% 4111
2021
Q1
$982K Buy
+81,191
New +$1.61M ﹤0.01% 3630

Other funds holding LHDX

State Street's LHDX Position: Q1 2023 in Review

State Street sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2023, closing a stake of 30,507 shares — an estimated $3.39K sold.

State Street first reported a position in LHDX in Q1 2021 and held it in 8 quarters. The position peaked at $982K in Q1 2021. 6 funds tracked by Wall St. Rank hold LHDX as of Q1 2023.

  • State Street reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • State Street sold 30,507 Lucira Health, Inc. Common Stock shares in Q1 2023, an estimated $3.39K.
  • State Street first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
  • State Street's Lucira Health, Inc. Common Stock position peaked at $982K in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2023.

Based on State Street's 13F filing for Q1 2023, filed 15 May 2023.